CTSO
Cytosorbents Corporation
Medical Devices · Healthcare · United States
4.54
close · 2026-10-30
value
2
cheaper than peers2
quality
6
stronger fundamentals6
ranked against
Medical Devices
value
quality
84 peerswide variation
Value inputs
| measure | company | vs peers |
| price to sales | 0.38× | 92 |
| earnings yield, latest year | -57.3% | 14 |
| cash flow yield, 1 year ago | -105.5% | 8 |
| earnings yield, 1 year ago | -167.4% | 7 |
| cash flow yield, latest year | -89.9% | 7 |
| earnings yield, 3 years ago | -328.8% | 6 |
| cash flow yield, 2 years ago | -157.9% | 3 |
| earnings yield, 2 years ago | -286.3% | 2 |
| cash flow yield, 3 years ago | -242.5% | 2 |
9 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | -24.6% | 35 |
| revenue growth | 0.2% | 23 |
| return on equity | -336.2% | 7 |
3 of 4 measures available
Facts
| market cap | $14M |
| free cash flow | -$3.5M |
| employees | 129 |
| first trade | 2006-08-08 |
| next earnings | 2026-11-12 |
| fundamentals updated | 2026-08-17 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -2.60 | -7.60 | -13.00 | -14.93 |
| free cash flow | -$12.9M | -$15.1M | -$22.6M | -$34.7M |
| net income | -$8.2M | -$20.7M | -$29.2M | -$32.8M |
| revenue | $37.1M | $35.6M | $31.1M | $29.4M |
| unusual items | $8.8M | -$4.2M | $1.9M | -$2.4M |